FR2611274B1 - Ensemble pour la detection du sida, procede de determination des risques de sida et composition therapeutique contre cette maladie - Google Patents

Ensemble pour la detection du sida, procede de determination des risques de sida et composition therapeutique contre cette maladie

Info

Publication number
FR2611274B1
FR2611274B1 FR8802119A FR8802119A FR2611274B1 FR 2611274 B1 FR2611274 B1 FR 2611274B1 FR 8802119 A FR8802119 A FR 8802119A FR 8802119 A FR8802119 A FR 8802119A FR 2611274 B1 FR2611274 B1 FR 2611274B1
Authority
FR
France
Prior art keywords
aids
same
determination method
therapeutic composition
detection assembly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8802119A
Other languages
English (en)
Other versions
FR2611274A1 (fr
Inventor
T. Imagawa David
H. Lee Moon
Sano Kouichi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RESEARCH EDUCATION INSTITUTE Inc
Original Assignee
RESEARCH EDUCATION INSTITUTE Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RESEARCH EDUCATION INSTITUTE Inc filed Critical RESEARCH EDUCATION INSTITUTE Inc
Publication of FR2611274A1 publication Critical patent/FR2611274A1/fr
Application granted granted Critical
Publication of FR2611274B1 publication Critical patent/FR2611274B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1072—Regulatory proteins, e.g. tat, rev, vpt
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR8802119A 1987-02-24 1988-02-23 Ensemble pour la detection du sida, procede de determination des risques de sida et composition therapeutique contre cette maladie Expired - Fee Related FR2611274B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/017,450 US4942122A (en) 1987-02-24 1987-02-24 Aids prognosis test detecting the presence of antibodies inhibiting HIV reverse transcriptase

Publications (2)

Publication Number Publication Date
FR2611274A1 FR2611274A1 (fr) 1988-08-26
FR2611274B1 true FR2611274B1 (fr) 1994-02-11

Family

ID=21782654

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8802119A Expired - Fee Related FR2611274B1 (fr) 1987-02-24 1988-02-23 Ensemble pour la detection du sida, procede de determination des risques de sida et composition therapeutique contre cette maladie

Country Status (7)

Country Link
US (1) US4942122A (fr)
JP (1) JPS63252253A (fr)
CA (1) CA1296623C (fr)
DE (1) DE3805331A1 (fr)
FR (1) FR2611274B1 (fr)
GB (1) GB2201775B (fr)
IT (1) IT1219844B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640145B1 (fr) * 1988-12-12 1991-08-23 Res Education Inst Inc Ensemble pour le traitement du sida
DE69021425T2 (de) * 1989-04-14 1996-04-25 Asahi Chemical Ind Verfahren zur Messung von Reverse-Transcriptase mit nichtradioaktiven Substanzen.
KR970002255B1 (ko) * 1990-06-11 1997-02-26 넥스스타 파아마슈티컬드, 인크. 핵산 리간드
DE4027616A1 (de) * 1990-08-31 1992-03-05 Boehringer Mannheim Gmbh Verfahren zur bestimmung von polymerase-aktivitaet
JP3011987B2 (ja) * 1990-10-11 2000-02-21 旭化成工業株式会社 固相化プライマーを用いる逆転写酵素の測定法
DE4041114C2 (de) * 1990-12-21 1994-02-17 Michael Dr Med Gruenspan Arzneimittel enthaltend eine IgG 2a-Antikörperfraktion aus Körperflüssigkeiten von HIV-infizierten Patienten
CA2221769C (fr) * 1995-05-26 2003-07-01 Asahi Kasei Kogyo Kabushiki Kaisha Methode de dosage d'anticorps inhibant l'activite de la transcriptase inverse
US7087375B1 (en) * 2000-06-23 2006-08-08 Johan Lennerstrand Method for determining the mechanism of HIV RT inhibitors
US20050147965A1 (en) * 2003-12-31 2005-07-07 Zhong Zhandong D. Compositions and methods for detecting reverse transcriptase in a sample
EP3187585A1 (fr) 2010-03-25 2017-07-05 Oregon Health&Science University Glycoprotéines de cytomégalovirus (cmv) et vecteurs de recombinaison
DK2691530T3 (en) 2011-06-10 2018-05-22 Univ Oregon Health & Science CMV GLYCOPROTEIN AND RECOMBINANT VECTORS
EP2568289A3 (fr) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunosélection du virus de la stomatite vésiculaire recombinant exprimant les protéines du VIH-1 par des anticorps largement neutralisants
EP2679596B1 (fr) 2012-06-27 2017-04-12 International Aids Vaccine Initiative Variante de la protéine env du VIH-1
EP2848937A1 (fr) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Procédés d'identification de nouveaux immunogènes du VIH-1
EP2873423B1 (fr) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Trimères de glycoprotéines d'enveloppe du vih -1 soluble
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (fr) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Trimères de glycoprotéines de l'enveloppe du vih-1 soluble
US9925258B2 (en) 2015-10-02 2018-03-27 International Aids Vaccine Initiative Replication-competent VSV-HIV Env vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707439A (en) * 1984-10-26 1987-11-17 The United States Of America As Represented By The Department Of Health And Human Services Screening test for reverse-transcriptase containing virus such as non-A, non-B hepatitis, NANBH

Also Published As

Publication number Publication date
IT8847663A0 (it) 1988-02-24
JPS63252253A (ja) 1988-10-19
GB2201775B (en) 1991-02-06
FR2611274A1 (fr) 1988-08-26
IT1219844B (it) 1990-05-24
US4942122A (en) 1990-07-17
CA1296623C (fr) 1992-03-03
DE3805331A1 (de) 1988-09-01
GB8804169D0 (en) 1988-03-23
GB2201775A (en) 1988-09-07

Similar Documents

Publication Publication Date Title
FR2611274B1 (fr) Ensemble pour la detection du sida, procede de determination des risques de sida et composition therapeutique contre cette maladie
BE892270A (fr) Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique
NL193218B (nl) Werkwijze voor de bereiding van roestvrij staal.
DE3854276D1 (de) Kathodenzerstäubungsverfahren und Vorrichtung zur Durchführung desselben.
NO894296L (no) Fremgangsmaate for behandling av leddgikt og betennelsessykdommer.
EP0513804A3 (en) Biosensor and method of quantitative analysis using the same
DE3865546D1 (de) Festkoerperszintillator und herstellungsverfahren.
AU1508588A (en) An apparatus for the treatment of biological samples and treatment methods using the same
AU8102391A (en) Methods for detecting and evaluating heart disorders
EP0238352A3 (en) Method for the selective detection of microbial nucleotides
FR2583038B1 (fr) Procede de deprotection des esters et ethers allyliques
FR2506306B1 (fr) Nouveaux derives de l'amidinopiperidine, leur procede de preparation et leur application en therapeutique
MA19331A1 (fr) Derives de la thieno - pyridinone , leur procede de preparation et leur application therapeutique .
FR2689508B1 (fr) Derives de l'imidazole, leur procede de preparation et leur application en therapeutique.
DE69009362D1 (de) Walzwerk und Walzverfahren.
MA21790A1 (fr) Derives de la thieno - triazolo - diazepine ainsi que leur procede de preparation .
NO880882D0 (no) Fremgangsmaate og middel for bestemmelse av hyaluronsyre.
MA21183A1 (fr) Composes arylpiperazinyl-alkylene-phenyl-heterocycliques et leur procede de preparation.
NO180181C (no) Fremgangsmåte for fremstilling av et is-kjernedannende protein, plasmider og bakteriestammer
NO882792D0 (no) Fremstilling og anvendelse av promotere for ekspresjon av fremmed-dna i metylotrofebakterier.
BE888332A (fr) Composes inhibiteurs de la biosynthese du cholesterol, leur procede de preparatio et de biosynthese du cholesterol. leur procede de preparation et leur application therapeutique,
FR2668031B1 (fr) Bouillies bordelaises et leur procede de preparation.
IT8720985A0 (it) Copolimero idrofilo e metodo per la sua produzione.
NO903801D0 (no) Alkalipullunase, mikroorganisme og fremgangsmaate ved fremstilling derav.
BE896478A (fr) DERIVES N-CARBAMOYLE D'ISOTHIAZOLO-(5,4b) PYRIDINE ONE-3 ET LEUR PROCEDE DE PREPARATION

Legal Events

Date Code Title Description
BR Restoration of rights
ST Notification of lapse